In breast cancer, the gene expression profile of tumors with FDG SUVmax > 10 showed an “FDG signature” that was enriched with glycolysis-related genes and associated with activation of the MYC transcription factor (c-Myc), a functional counterpart of MYCN [33]. Here, MYCN is linked to breast cancer.